Anti-platelet drugs, pharmacogenomics and stent thrombosis: What’s new?
Stent thrombosis is a catastrophic complication of percutaneous coronary intervention (PCI) and is associated with a mortality of 25 to 40%. The perception that stent thrombosis is very low in all patients has resulted in a lack of adherence to professional guidelines. New data to identify patients...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
South African Heart Association
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/30784cb229da45439b3270debb1493bc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|